Nattapron Tun
Hematology & Oncology · Frisco, TXNPI 1225597388
Payments from drug & device makers
Across 71 payments — averaging $38.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$536
- Sanofi$491
- AstraZeneca$341
- Gilead$308
- Pfizer$193
- Bristol Myers Squibb$142
- plus $749 from 17 others
What the payments were for
- Food & beverage$2,40887%
- Education$35113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 8 | $536 |
| Sanofi | 10 | $491 |
| AstraZeneca(2 entities) | 11 | $341 |
| Gilead(2 entities) | 5 | $308 |
| Pfizer | 4 | $193 |
| Bristol Myers Squibb | 5 | $142 |
| Astellas Pharma US Inc | 2 | $125 |
| Merck | 3 | $87 |
| Daiichi Sankyo Inc. | 3 | $80 |
| Eisai Inc. | 3 | $74 |
| Genentech USA, Inc. | 2 | $55 |
| Agios Pharmaceuticals, Inc. | 2 | $45 |
| Bayer | 2 | $39 |
| Novartis | 2 | $37 |
| Lilly USA, LLC | 1 | $34 |
| Myriad Genetic Laboratories, Inc. | 1 | $28 |
| Karyopharm Therapeutics Inc. | 1 | $25 |
| Mirati Therapeutics, Inc. | 1 | $24 |
| AbbVie | 1 | $23 |
| Stemline Therapeutics Inc. | 1 | $22 |
| Array Biopharma Inc | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Iovance Biotherapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,760 in reported general payments places this provider in the 30th percentile of 838 hematology & oncology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 12 | $19 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Frisco
- Elias JabbourHouston$264.1M
- Luhua WangHouston$79.6M
- Courtney DinardoHouston$74M
- Jorge Cortes-FrancoHouston$59.4M
- William WierdaHouston$58.7M
- Koji SasakiHouston$39.2M
- Kyriakos PapadopoulosSan Antonio$18.5M
- Loretta NastoupilHouston$18.3M
- Christopher FlowersHouston$17.2M
- Drew RascoSan Antonio$14.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.